Renlife Labs Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 16.00 Cr
About Renlife Labs
Renlife Labs Private Limited (RLPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 November 2017 (Seven years and two months 11 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹16.00 Cr.
Vijay Raghavendra, Arul Ramakrishnan, and Mohammad Azeez serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290TG2017PTC120880
-
Company No.
120880
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Nov 2017
-
Date of AGM
31 Dec 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Renlife Labs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Raghavendra
|
Director | 20-Feb-2018 | Current |
|
Arul Ramakrishnan
|
Director | 29-Nov-2017 | Current |
|
Mohammad Azeez
|
Director | 29-Nov-2017 | Current |
Financial Performance of Renlife Labs.
Renlife Labs Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Renlife Labs?
In 2018, Renlife Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vigilm Lifestyle Services Private LimitedVijay Raghavendra is a mutual person
-
Dalchemy Labs India Private Limited
Vijay Raghavendra is a mutual person
-
Abundant Promotions India Private Limited
Vijay Raghavendra is a mutual person
-
Stepping Stone Clinical Research India Private Limited
Arul Ramakrishnan is a mutual person
Charges (Loans)
₹16.00 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 16.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Aug 2018 | State Bank Of India | ₹16.00 Cr | Open |
How Many Employees Work at Renlife Labs?
Unlock and access historical data on people associated with Renlife Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Renlife Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renlife Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.